Clinical Trial Update: A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for iron oligosaccharide in chronic kidney disease patients with iron-deficiency anemia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Iron Oligosaccharide (iron oligosaccharide)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Chronic Kidney Disease, Anemia, Iron-Deficiency | Phase 3 | Status: COMPLETED